Enliven Therapeutics, Inc.

ELVN ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
4 Oct 21, 2026
4 Oct 21, 2026
144 Oct 19, 2026
4 Oct 16, 2026
3 Oct 16, 2026
8-K Oct 14, 2026 8-K
4 Oct 5, 2026
144 Oct 1, 2026
4 Sep 21, 2026
4 Sep 21, 2026
144 Sep 17, 2026
144 Sep 4, 2026
4 Aug 19, 2026
4 Aug 19, 2026
4 Aug 6, 2026
SCHEDULE 13G/A Aug 6, 2026
10-Q Aug 5, 2026 10-Q
8-K Aug 5, 2026 8-K
144 Aug 4, 2026
4 Jul 21, 2026
4 Jul 21, 2026
144 Jul 17, 2026
4 Jul 8, 2026
4 Jun 24, 2026
SCHEDULE 13D/A Jun 24, 2026
← Newer Page 1 of 32 · 794 filings Older →